Barriers and enablers to the implementation of multidisciplinary team meetings: a qualitative study using the theoretical domains framework.

clinical practice guidelines health services research implementation science patient-centred care quality improvement

Journal

BMJ quality & safety
ISSN: 2044-5423
Titre abrégé: BMJ Qual Saf
Pays: England
ID NLM: 101546984

Informations de publication

Date de publication:
10 2021
Historique:
received: 16 06 2020
revised: 18 10 2020
accepted: 29 10 2020
pubmed: 29 11 2020
medline: 28 10 2021
entrez: 28 11 2020
Statut: ppublish

Résumé

Evidence-based clinical practice guidelines recommend discussion by a multidisciplinary team (MDT) to review and plan the management of patients for a variety of cancers. However, not all patients diagnosed with cancer are presented at an MDT. (1) To identify the factors (barriers and enablers) influencing presentation of all patients to, and the perceived value of, MDT meetings in the management of patients with pancreatic cancer and; (2) to identify potential interventions that could overcome modifiable barriers and enhance enablers using the theoretical domains framework (TDF). Semistructured interviews were conducted with radiologists, surgeons, medical and radiation oncologists, gastroenterologists, palliative care specialists and nurse specialists based in New South Wales and Victoria, Australia. Interviews were conducted either in person or via videoconferencing. All interviews were recorded, transcribed verbatim, deidentified and data were thematically coded according to the 12 domains explored within the TDF. Common belief statements were generated to compare the variation between participant responses. In total, 29 specialists were interviewed over a 4-month period. Twenty-two themes and 40 belief statements relevant to all the TDF domains were generated. Key enablers influencing MDT practices included a strong organisational focus ( The internal and external organisational structures surrounding MDT meetings ideally need to be strengthened with the development of agreed evidence-based protocols and referral pathways, a focus on resource allocation and capabilities, and a culture that fosters widespread collaboration for all stages of pancreatic cancer.

Sections du résumé

BACKGROUND
Evidence-based clinical practice guidelines recommend discussion by a multidisciplinary team (MDT) to review and plan the management of patients for a variety of cancers. However, not all patients diagnosed with cancer are presented at an MDT.
OBJECTIVES
(1) To identify the factors (barriers and enablers) influencing presentation of all patients to, and the perceived value of, MDT meetings in the management of patients with pancreatic cancer and; (2) to identify potential interventions that could overcome modifiable barriers and enhance enablers using the theoretical domains framework (TDF).
METHODS
Semistructured interviews were conducted with radiologists, surgeons, medical and radiation oncologists, gastroenterologists, palliative care specialists and nurse specialists based in New South Wales and Victoria, Australia. Interviews were conducted either in person or via videoconferencing. All interviews were recorded, transcribed verbatim, deidentified and data were thematically coded according to the 12 domains explored within the TDF. Common belief statements were generated to compare the variation between participant responses.
RESULTS
In total, 29 specialists were interviewed over a 4-month period. Twenty-two themes and 40 belief statements relevant to all the TDF domains were generated. Key enablers influencing MDT practices included a strong organisational focus (
CONCLUSIONS
The internal and external organisational structures surrounding MDT meetings ideally need to be strengthened with the development of agreed evidence-based protocols and referral pathways, a focus on resource allocation and capabilities, and a culture that fosters widespread collaboration for all stages of pancreatic cancer.

Identifiants

pubmed: 33247002
pii: bmjqs-2020-011793
doi: 10.1136/bmjqs-2020-011793
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

792-803

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Ashika D Maharaj (AD)

Monash University Faculty of Medicine, Nursing and Health Sciences, Melbourne, Victoria, Australia.

Sue M Evans (SM)

Monash University Faculty of Medicine, Nursing and Health Sciences, Melbourne, Victoria, Australia.
Cancer Council Victoria, Melbourne, Victoria, Australia.

John R Zalcberg (JR)

Monash University Faculty of Medicine, Nursing and Health Sciences, Melbourne, Victoria, Australia.
Alfred Health, Melbourne, Victoria, Australia.

Liane J Ioannou (LJ)

Monash University Faculty of Medicine, Nursing and Health Sciences, Melbourne, Victoria, Australia.

Marnie Graco (M)

Alfred Health, Melbourne, Victoria, Australia.

Daniel Croagh (D)

Monash Health, Clayton, Victoria, Australia.

Charles H C Pilgrim (CHC)

Alfred Health, Melbourne, Victoria, Australia.

Theresa Dodson (T)

Monash Health, Clayton, Victoria, Australia.

David Goldstein (D)

UNSW Prince of Wales Clinical School, Randwick, New South Wales, Australia.

Jennifer Philip (J)

St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.
University of Melbourne, VCCC, Parkville, Victoria, Australia.

James G Kench (JG)

Royal Prince Albert Hospital, Camperdown, New South Wales, Australia.

Neil D Merrett (ND)

Western Sydney University, Penrith South, New South Wales, Australia.

Rachel E Neale (RE)

QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.

Kate White (K)

Sydney Nursing School, Sydney, New South Wales, Australia.

Peter Evans (P)

Peninsula Health, Frankston, Victoria, Australia.

Trevor Leong (T)

Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Sally E Green (SE)

Monash University Faculty of Medicine, Nursing and Health Sciences, Melbourne, Victoria, Australia sally.green@monash.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH